Understanding Patient Perceptions and Risk for Hepatitis C Screening Sheriedan Grannan, MS, RN, CHES DNP-candidate Diane Boyle, PhD, RN, FAAN.

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

Hepatitis C in Retrospect David Gladders Portsmouth City Council.
African Americans and Hepatitis C
Perspectives on Outreach from the NYC Department of Health and Mental Hygiene Benjamin Tsoi, MD, MPH Bureau of HIV/AIDS Prevention and Control NYC Department.
Integration of Viral Hepatitis Prevention with STD Prevention: What Health Professionals Should Know Presenter: Jay Todd, Training and Public Education.
Increased routine screening for syphilis and falling syphilis incidence in HIV positive and HIV negative men who have sex with men: implications for syphilis.
Performance Improvement Assessment of Services Provided by the Vaccine and International Travel Center Vidyulata Salunkhe MD 1, Ruth Carrico PhD RN 2,
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
Hepatitis C In Alaska’s Department of Corrections
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
Is this Research? Exempt? Expedited?
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Perinatal HIV Testing in Utah Lois Blobaum, BSN, Theresa Garrett, MSN and Nan Streeter, RN, MS Utah Department of Health.
Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users Hans Blystad 1 and.
EVALUATING HIV AWARENESS AMONG OBSTETRIC POPULATION AT A PUBLIC HOSPITAL IN MALAYSIA Nazimah Idris, Pow Jun Yan, Sak Yeow Hong, Lavanya Narayanan, Lukmanul.
SANTANA P. ABRAVANEL L., AUBERT JP.PICARD H. GELLY J. FRARIER M. 1 PREVAC A An evaluation of preventive Hepatitis A vaccination in risk groups WONCA EUROPE.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington.
The Health Seeking Behaviors of Young African American Males and Their Thoughts About Prostate Cancer Veronica A. Clarke-Tasker, Ph.D., RN, MBA, MPH, Professor.
RCGP training online: new training in short bites Danny Morris, Expert Lead RCGP Hepatitis B and C Part 1.
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
ABSTRACT Introduction: HIV infection is growing relatively fast among seniors. Among the clinical implications are that older patients have less ability.
Electronic Health Records and Clinical Decision Support Systems Impact on National Ambulatory Care Quality Max J. Romano, BA; Randall S. Stafford, MD,
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
John W. Hogan, M.D Howard University College of Medicine.
Sara Stevenson Hepatitis B Nurse Specialist St James’s Hospital, Leeds.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Understanding Why Patients Accept Vaccination: A Socio-Behavioral Approach at the University of Louisville Vaccine and International Health and Travel.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Scioto County Medical Society Grand Rounds March 31, 2006 Portsmouth, Ohio Kathleen M. Koechlin, RN, MPH, PhD Hepatitis C Coordinator The Ohio Department.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs.
“I Just Did It”: Health Decision Making and Perceived Outcomes of HIV Testing in the African American Church ALEXANDRIA BOOKER, BAJANNETTE BERKLEY-PATTON,
HIV Testing in Medical Settings Mark Thrun, MD Denver Public Health
Predicting Nurse Practitioners’ Intentions and Behaviors to Perform Routine HIV Screening Jodi L. Sutherland, PhD, RN Gale A. Spencer, PhD, RN Binghamton.
A Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department – a call for widespread ED testing in Ireland S O’Connell 1, D Lillis.
Connecting Hypertensive Patients at the Physican’s Free Clinic to a Primary Care Provider Ariel Kanevsky, Ranjit Ganguly, Brittany Shrefler, Maarten Galantowicz.
Public health impacts of donor screening for T. cruzi infection Susan P. Montgomery, DVM MPH Division of Parasitic Diseases Centers for Disease Control.
Janet Lin, MD, MPH, Sweta Basnet, MS, Sara Baghikar, MD, Cammeo Mauntel-Medici, MPH, Sara Heinert, MPH University of Illinois at Chicago, College of Medicine,
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
Importance of HIV Education of HIV Screening and Risk Among Adults 65 Years Old and Older In A Senior Center JESSICA WARD RN,BSN,FNP COPPIN STATE UNIVERSITY.
Depression Screening in Primary Care and Impact on Suicide Prevention Anne-Marie T. Mann, BSN, RN, DNP Candidate Diane Kay Boyle, PhD, RN, FAAN.
Beliefs about Male Circumcision among Men from a Traditionally Non- Circumcising Community in Rural Western Kenya, Adega, A, Burmen, B, Mutai,
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Baseline Assessment of Nurses’ Experiences and Attitudes regarding Expanded HIV Testing in the Emergency Department at LIJ November 2014 Jenny Doyle,NSLIJ.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Template ID: junglegreens Size: 36x48 Impact of Hepatitis C Screening in Outpatient Population Madhuri Chandnani MD, Pallavi Pothuri MD, Michael Stevens.
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Stacey B Trooskin MD PhD
What Are the Barriers to Opt-out HIV testing?
Massachusetts Department of Public Health
Cascade of care for persons newly diagnosed
Hepatitis C Incidence and Prevalence in the U.S.
Rowe, KA1, Tesoriero, JM1, Davis, SJ1, Heavner, KK1, Rothman, J2,
A qualitative assessment of factors impacting adoption and implementation of USPSTF age-based hepatitis C virus screening recommendations Amy B. Jessop,
Building a Data Driven HCV Screening and Linkage-to-Care Program
Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D
HCV: Who Should We Screen and Why?
HCV Screening.
FACTORS ASSOCIATED WITH RECEIPT OF HEPATITIS B VACCINE AMONG HIGH RISK ADULTS NATIONAL HEALTH INTERVIEW SURVEY, 2000 Nidhi Jain MD MPH The topic of my.
Progress in Facilitating National HCV Prevention
TRACE INITIATIVE: HIV Testing Services (HTS)
Presentation transcript:

Understanding Patient Perceptions and Risk for Hepatitis C Screening Sheriedan Grannan, MS, RN, CHES DNP-candidate Diane Boyle, PhD, RN, FAAN

Introduction HCV infections are a significant burden on individual and community health CDC reported Approximately 17,000 new HCV infections in million people living with HCV in US 45% to 85% of viral hepatitis C infections go undiagnosed even though testing is available The Baby Boomer ( ) generation and underserved populations continue to carry the brunt of diagnosed and undiagnosed HCV infections

Purpose and Aims Overall project objectives are to: 1)Examine the reasons that adults do not want to test for HCV infections 2)To increase awareness of risk factors and infection The specific aims are to: 1)Identify specific themes and barriers to Hepatitis C testing 2)Determine if testing rates increase when patients self-identify their risk factors and are offered testing.

Methods Descriptive study Survey and group-level electronic health record (EHR) data. Survey Assessment 01/09/15-03/20/15 Survey inclusion criteria Adults (18 years old and older) that speak and write in English or Spanish arriving for care at a FQHC in the Mountain West

Human Subject Committee approval from the University of Wyoming Institutional Review Board (UW IRB) One paragraph script used by FQHC staff to offer surveys to all adult patients that could read English or Spanish at the time of check-in Cover letter explaining the project attached to survey Complete and incomplete surveys were placed in an envelope in the exam room by the patient for confidentiality A slip of paper requesting HCV testing was attached to each survey Questionnaire took minutes to complete Procedures

Participant Characteristics N=111, 3% of FQHC patient panel completed surveys

Frequency of Self-identified Risk

Self-identified Risk Factors Participants that identified as being born , only 78% identified being born as a risk factor Those that identified as ever using injection drugs, 62.5% belong to the Baby Boomer ( ) age group Those that identified a previous diagnosis of HCV, 60% belong to the Baby Boomer age group and 40% to age group

Intent to Test Of those that answered, 81% of participants did not want to test for HCV 2% indicated that they would have asked to test despite the survey Of participants that indicated a risk of born , 15.8% intended to test for HCV Of those that indicated injection drug use, 28.6% intended to test 35% of those with a risk of multiple sex partners intended to test

Intent to Test Of those that indicated non-injection drug use as a risk factor, 11.1% intended to test 19.6% of those with tattoos or body piercings intended to test 2.9 tests per week were done in tests per week were done during 10 week survey period

Main Reasons Not to Test “I do not think I have any risk factors” was the most common with 30.2% 17% selected more than one main reason 15.1% were concerned with cost 15.1% had tested in the past 9.3% had other reasons 5.8% were not feeling well 4.7% did not want a blood draw 1.2% were worried the test would be positive 1.2% do not feel comfortable being tested at the FQHC No one selected “provider did not say I needed it”

Additional Reasons Not to Test 18.9% felt they had no risk 14.4% had tested in the past 9.9% were concerned with cost of testing 8.1% listed other reasons 6.3% stated the provider did not tell them they needed it 6.3% did not feel well 3.6% did not want a blood draw 2.7% did not feel comfortable being tested at the FQHC 0.9% were worried the result would be positive

Discussion Baby Boomers fail to identify being born as a risk factor even after provided with testing recommendations and information about risk Significant portion of those in the Baby Boomer generation identified injection drug use, non- injection drug use and/or tattoos and/or body piercings risks

Discussion Only a small number of Baby Boomers indicated that s/he would test for HCV that day Screening of those born needs to occur in greater numbers A multifaceted approach to make testing commonplace for all Baby Boomers Printed materials in patient areas Providers to discuss screening during an annual well person exam Risk based screening is recommended for all those not in the Baby Boomer generation

Discussion Concern with cost Providing information about cost and coverage options Staff should be knowledgeable of insurance coverage and local programs that offer free or reduced testing Comfort in testing at the clinic Staff should ensure confidentiality and demonstrate knowledge about HCV, testing and treatment Be non-judgmental and strive to make HCV testing a routine aspect of care to reduce stigma Assessments should be done to identify specific areas of concern for patient comfort and patient suggestions for improvement

Questions

References Centers for Disease Control and Prevention. MMWR: Recommendations for the identification of chronic hepatitis c virus infections among persons born during MMWR 2012; 61(No. RR-4):p Centers for Disease Control and Prevention. The ABCs of hepatitis. U.S. Department of Health and Human Services. Publication No (2012, accessed 12 October 2014). Smith BD, Yartel AK, Krauskopf K, Massoud OI, Brown KA, Fallon MB, Rein DB. Hepatitis c virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: Cross-sectional analysis of a multisite retrospective cohort study. Clinical Infectious Diseases 2015; JAN 29. p. 1-8 Nguyen MT, Herrine SK, Laine CA, Ruth K, Weinberg DS. Description of a new hepatitis c risk assessment tool. Arch Intern Med 2005; 165(SEP 26). Reprinted Barocas JA, Brennan MB, Hull SJ, Stokes S, Fangman JJ, Westergaard RP. Barriers and facilitators of hepatitis c screening among people who inject drugs: a multi-city, mixed- methods study. Harm Reducation Journal 2014; 11(1). Ubhayakar ND, Lindsell CJ, Raab DL, Ruffner AH, Trott AT, Fichtenbaum CJ, Lyons MS. Risk, reasons for refusal, and impact of counseling on consent among ED patients declining HIV screening. American Journal of Emergency Medicine 2009; 29, p